(Q73555375)
Statements
Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia (English)
Dibenedetto SP
Lo Nigro L
Mayer SP
Rovera G
scientific article published on 01 August 1997
No description defined